Reference library record. This work was written and published by the people and publisher named here. It is listed in the Sterling IMRES reference library for study and citation. Sterling IMRES did not author or publish it, and listing a work does not mean its authors are affiliated with the institute. Metadata verified via Crossref. How records are verified
Summary
Publishes the CONSORT 2025 statement, the first major revision of the trial reporting guideline since 2010, with an updated checklist and flow diagram. It adds items on topics such as open science and harms, and was developed through a consensus process involving a large international group.
Summary written by Sterling IMRES editors. Read the original abstract at the publisher.
Asbjørn HróbjartssonCentre for Evidence-Based Medicine Odense and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Open Patient data Explorative Network, Odense University Hospital, Odense, DenmarkORCID 0000-0002-2451-5012
David MoherCentre for Journalology, Clinical Epidemiology Programme, Ottawa Hospital Research Institute, Ottawa, ON, CanadaORCID 0000-0003-2434-4206
Kenneth F SchulzDepartment of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAORCID 0000-0003-2596-7616
Ruth TunnOxford Clinical Trials Research Unit, Centre for Statistics in Medicine, University of Oxford, Oxford OX3 7LD, UKORCID 0000-0003-1187-1808
Jesse A BerlinDepartment of Biostatistics and Epidemiology, School of Public Health, Center for Pharmacoepidemiology and Treatment Science, Rutgers University, New Brunswick, NJ, USA; JAMA Network Open, Chicago, IL, USAORCID 0000-0002-9810-745X
The full author list is available from the publisher.
Cite this work
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, Moher D, Schulz KF, et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ. 2025;389:e081123. doi:10.1136/bmj-2024-081123
